文献速递围术期管理与 ERAS

普通外科与骨科医生处理四肢软组织肉瘤的患者特征、结局与趋势

Patient characteristics, outcomes, and trends in extremity sarcoma management by surgeon specialty.
PubMed 文献 · Surgery · 2021-05-21

基于2008至2017年NSQIP数据库,比较普通外科与骨科医生行四肢软组织肉瘤保肢切除术的患者特征与结局。普通外科病例占多数(304例,69.4%),但其手术量显著下降(年百分比变化-5.8,P<.0001)。两专科30天总并发症率(7.2% vs 9.7%,P=.38)与全因死亡率(0.3% vs 0%,P=.51)无差异,但围术期管理存在差异。

要点

  • 普通外科医生行四肢软组织肉瘤保肢切除术占多数,但研究期间手术量显著下降。
  • 两专科30天总并发症率与全因死亡率无显著差异。
  • 骨科医生病例更常使用区域麻醉、术后输血且住院时间更长。

核心结论

  • 普通外科与骨科医生行四肢软组织肉瘤保肢切除术的术后结局相当,但治疗与围术期管理存在差异。

研究设计与样本

  • 回顾性队列研究,数据来自2008至2017年美国国家手术质量改进计划(NSQIP)数据库,纳入行四肢软组织肉瘤保肢切除术的患者,比较普通外科与骨科医生。

主要发现

  • 普通外科医生完成多数病例(N=304,69.4%),但其手术量在研究期间显著下降(35.2%),年百分比变化为-5.8(P<.0001)。
  • 普通外科患者接受新辅助化疗的比例更低(2.0% vs 3.7%,P<.01),接受新辅助放疗的比例更高(9.9% vs 5.2%,P<.01),术前白细胞计数正常者比例更高(77.0% vs 66.4%,P=.02)。
  • 骨科医生病例更常采用区域麻醉(9.7% vs 2.3%,P=.01),术后输血比例更高(5.2% vs 0.3%,P<.01),中位住院时间更长(2天 vs 1天,P<.01)。
  • 30天总并发症率(普通外科7.2% vs 骨科9.7%,P=.38)与全因死亡率(普通外科0.3% vs 骨科0%,P=.51)无显著差异。

临床怎么用

  • 普通外科医生应关注四肢软组织肉瘤手术量下降的趋势,并注意与新辅助治疗及围术期管理相关的专科差异。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extremity soft tissue sarcoma is managed by oncological trained general or orthopedic surgeons, but limited data exist comparing patient characteristics and outcomes between the 2 specialties. METHODS: Patients were identified from the 2008 to 2017 National Surgical Quality Improvement Program who underwent limb-sparing resection of extremity soft tissue sarcoma by either general surgeons or orthopedic surgeons. Multivariable logistic regression analysis identified factors associated with general surgeons compared with OS. Length of stay was assessed using Poisson regression. Procedure annual percent change was analyzed using Joinpoint Regression. RESULTS: The majority of extremity soft tissue sarcoma cases were performed by general surgeons (N = 304, 69.4%), but general surgeons' resections significantly decreased (35.2%) over the study period (annual percent change -5.8, P < .0001). General surgeons' patients were less likely to receive neoadjuvant chemotherapy (2.0% vs 3.7%, P < .01), and more likely to receive neoadjuvant radiation (9.9% vs 5.2%, P < .01) and have normal preoperative white blood cell counts (77.0% vs. 66.4%, P = .02). Orthopedic surgeons' cases were more often performed under regional anesthesia (9.7% vs. 2.3%, P = .01), and orthopedic patients were more likely to receive postoperative transfusions (5.2% vs 0.3%, P < .01) and had a longer median length of stay (2 vs 1 days, P < .01). Thirty-day overall morbidity (7.2% general surgeon vs 9.7% orthopedic surgeon, P = .38) and all-cause mortality (0.3% general surgeon vs 0% orthopedic surgeon, P = .51) did not differ by specialty. CONCLUSION: Although postoperative outcomes for extremity soft tissue sarcoma are comparable between general and orthopedic surgeons, treatment and perioperative management differences exist. Future investigation focused on understanding these differences in perioperative management across specialties may help identify areas for quality improvement in care of patients with extremity soft tissue sarcoma.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Shannon AB, Straker RJ, Song Y, et al. Patient characteristics, outcomes, and trends in extremity sarcoma management by surgeon specialty. Surgery. 2021. PMID: 34024475. doi:10.1016/j.surg.2021.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。